Stem cell-based therapies in cardiovascular diseases: from pathophysiology to clinical outcomes.

pathophysiological mechanisms of stem-cell action stem cell in coronary artery disease stem cell paracrine signaling stem cell-based therapies in atherosclerosis stem cells stem cells in clinical studies

Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
28 Aug 2023
Historique:
received: 10 05 2023
revised: 18 06 2023
accepted: 19 07 2023
medline: 29 8 2023
pubmed: 29 8 2023
entrez: 29 8 2023
Statut: aheadofprint

Résumé

Over 20 years of intensified research in the field of stem cells brought about unprecedented possibilities in treating heart diseases. The investigators were initially fascinated by the idea of regenerating the lost myocardium and replacing it with new functional cardiomyocytes, but this was extremely challenging. However, the multifactorial effects of stem cell-based therapies beyond mere cardiomyocyte generation, caused by paracrine signaling, would open up new possibilities in treating cardiovascular diseases. To date, there is a strong body of evidence that the anti-inflammatory, anti-apoptotic, and immunomodulatory effects of stem cell therapy may alleviate atherosclerosis progression. In the present review, our objective is to provide a brief overview of the stem cell-based therapeutic options. We aim to delineate the pathophysiological mechanisms of their beneficial effects in cardiovascular diseases especially in coronary artery disease and to highlight some conclusions from important clinical studies in the field of regenerative medicine in cardiovascular diseases and how we could further move onwards.

Identifiants

pubmed: 37641986
pii: CPD-EPUB-134094
doi: 10.2174/1381612829666230828102130
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Charalampos Papastamos (C)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Alexios S Antonopoulos (AS)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Spyridon Simantiris (S)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Nikolaos Koumallos (N)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Panagiotis Theofilis (P)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Marios Sagris (M)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Konstantinos Tsioufis (K)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Emmanuel Androulakis (E)

Department of Cardiology, St George's University Hospital, London, UK.

Dimitris Tousoulis (D)

1st Cardiology Department, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.

Classifications MeSH